ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Above 50-Day Moving Average – Here’s What Happened

Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $90.03 and traded as high as $99.53. ProShares Ultra Nasdaq Biotechnology shares last traded at $99.53, with a volume of 5,066 shares traded.

ProShares Ultra Nasdaq Biotechnology Trading Up 1.7%

The firm has a 50-day moving average price of $90.25 and a 200-day moving average price of $85.70. The company has a market capitalization of $83.20 million, a price-to-earnings ratio of 20.68 and a beta of 1.19.

Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Kaizen Financial Strategies purchased a new position in ProShares Ultra Nasdaq Biotechnology in the 4th quarter worth about $424,000. Citadel Advisors LLC acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the third quarter worth approximately $307,000. Finally, Franklin Resources Inc. purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 2nd quarter valued at $32,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.